- Home
- GIPR vs EDSA Comparison
GIPR vs EDSA Comparison
Compare GIPR & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIPR
- EDSA
- Stock Information
- Founded
- GIPR 2015
- EDSA 2015
- Country
- GIPR United States
- EDSA Canada
- Employees
- GIPR N/A
- EDSA N/A
- Industry
- GIPR Real Estate Investment Trusts
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- GIPR Real Estate
- EDSA Health Care
- Exchange
- GIPR Nasdaq
- EDSA Nasdaq
- Market Cap
- GIPR 7.7M
- EDSA 13.8M
- IPO Year
- GIPR 2021
- EDSA N/A
- Fundamental
- Price
- GIPR $1.48
- EDSA $2.09
- Analyst Decision
- GIPR
- EDSA Strong Buy
- Analyst Count
- GIPR 0
- EDSA 2
- Target Price
- GIPR N/A
- EDSA $13.00
- AVG Volume (30 Days)
- GIPR 17.5K
- EDSA 13.1K
- Earning Date
- GIPR 08-14-2025
- EDSA 08-08-2025
- Dividend Yield
- GIPR N/A
- EDSA N/A
- EPS Growth
- GIPR N/A
- EDSA N/A
- EPS
- GIPR N/A
- EDSA N/A
- Revenue
- GIPR $9,711,058.00
- EDSA N/A
- Revenue This Year
- GIPR N/A
- EDSA N/A
- Revenue Next Year
- GIPR N/A
- EDSA N/A
- P/E Ratio
- GIPR N/A
- EDSA N/A
- Revenue Growth
- GIPR 11.25
- EDSA N/A
- 52 Week Low
- GIPR $1.33
- EDSA $1.55
- 52 Week High
- GIPR $3.93
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- GIPR 53.13
- EDSA 55.09
- Support Level
- GIPR $1.46
- EDSA $2.03
- Resistance Level
- GIPR $1.59
- EDSA $2.11
- Average True Range (ATR)
- GIPR 0.07
- EDSA 0.10
- MACD
- GIPR 0.01
- EDSA 0.01
- Stochastic Oscillator
- GIPR 68.99
- EDSA 73.33
About GIPR Generation Income Properties Inc.
Generation Income Properties Inc is an internally managed real estate investment company focused on acquiring and managing income-producing retail, office and industrial properties net leased to high-quality tenants in markets throughout the United States. Its key source of revenue is the rental income. The company holds properties in Alabama, Arizona, Colorado, the District of Columbia, Florida, Illinois, North Carolina and Virginia.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.